BAL PHARMA LTD. - Outcome of Board Meeting

Bal Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 20, 2014, inter alia, transacted the following business:<br/><br/>- After obtaining the approvals from the members, stock exchanges and other regulatory agencies and after having received the 25% of the initial consideration amount from the subscribers, the Board has approved the issue and allotment of 13,00,000 warrants to the subscribers on preferential basis, at a conversion price of Rs.62/- per warrant.